1,683
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Recombinant ferritins for multimodal nanomedicine

, , , , &
Article: 2219868 | Received 24 Apr 2023, Accepted 25 May 2023, Published online: 01 Jun 2023

Figures & data

Figure 1. Recombinant ferritin induces high levels of neutralising antibodies.

Figure 1. Recombinant ferritin induces high levels of neutralising antibodies.

Figure 2. Long-term efficacy of ferritin nanovaccine.

Figure 2. Long-term efficacy of ferritin nanovaccine.

Figure 3. Pt-ferritin develops peroxidase activity to improve the tumour hypoxic microenvironment pO2, thus making it more sensitive to chemotherapy and radiotherapy.

Figure 3. Pt-ferritin develops peroxidase activity to improve the tumour hypoxic microenvironment pO2, thus making it more sensitive to chemotherapy and radiotherapy.

Figure 4. Thermal stability of recombinant ferritin nanozymes.

Figure 4. Thermal stability of recombinant ferritin nanozymes.

Figure 5. Targeted inductions of cancer cell apoptosis by recombinant ferritin.

Figure 5. Targeted inductions of cancer cell apoptosis by recombinant ferritin.

Figure 6. Recombinant ferritin delivery of Cyt c induces in APLs cell apoptosis and nanodrug-0504 inhibits proliferation of pancreatic cancer cells.

Figure 6. Recombinant ferritin delivery of Cyt c induces in APLs cell apoptosis and nanodrug-0504 inhibits proliferation of pancreatic cancer cells.

Figure 7. Recombinant ferritin in bone imaging.

Figure 7. Recombinant ferritin in bone imaging.

Table 1. A summary of recombinant ferritin in multimodal nanomedicine.